| Appearance | White to off-white crystalline powder |
| Melting Point | 146–149°C |
| IUPAC Name | 5-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole |
| Molecular Formula | C13H16N2 |
| Molecular Weight | 200.28 g/mol |
| Solubility | Soluble in DMSO (>10 mM) |
| CAS Number | 113775-47-6 |
| MDL Number | MFCD00880557 |
| PubChem CID | 5311068 |
| FDA UNII | 67VB76HONO |
| InChIKey | CUHVIMMYOGQXCV-NSHDSACASA-N |
| Isomeric SMILES | CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C |
Dexmedetomidine is the single, pharmacologically active S-enantiomer of medetomidine, a synthetic imidazole known as a highly selective alpha-2 adrenergic receptor agonist. Under the brand Precedex it’s an FDA-approved sedative used clinically by licensed practitioners — but Sarchem Labs offers CAS 113775-47-6 strictly as a bulk research/analytical-grade chemical, not that finished drug product.
Used as an analytical reference standard for HPLC/LC-MS method development and identity/purity confirmation, and as a pharmacology tool compound to study alpha-2 receptor binding and signaling in vitro. Process chemists also reference it during route scouting or stereochemical comparison against racemic medetomidine.
No related products found.
As an analytical reference standard and alpha-2 adrenergic receptor pharmacology tool compound.
No — it's a research/analytical-grade bulk chemical. The FDA-approved clinical form (Precedex) is available only through licensed pharmaceutical channels.
113775-47-6, C13H16N2, MW ~200.28 g/mol.
Yes — GHS Danger: skin sensitization (H317), reproductive toxicity (H360), organ damage from repeated exposure (H373); also pharmacologically potent, handle with full PPE.
Dexmedetomidine is the single active S-enantiomer isolated from medetomidine, the racemic (mixed) form; the R-enantiomer contributes little receptor activity.